AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

LIVN · NASDAQ · Medical - Devices

LivaNova (LIVN)

Builds heart-lung systems and implantable stimulation devices for epilepsy, depression and sleep apnea.

$78.07

vs last close−0.42 (−0.54%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	286	310	295	319	318	322	317	353	358	361	362	391
Cost of revenue	84	120	88	104	93	102	96	114	113	121	117	117
Gross profit	202	190	207	215	225	219	221	239	245	240	245	274
	197	278	191	175	190	182	172	185	191	197	193	224
Research & development	47	46	46	45	49	43	38	47	49	52	49	54
Selling, general & administrative	135	133	130	125	132	136	134	138	139	143	144	158
Other expenses	16	99	16	5	9	3	1	0	4	2	0	12
Operating income	4	−88	16	40	36	37	49	54	54	43	52	50
	−6	−6	−50	−19	9	19	−364	−21	−20	−15	−26	−31
Interest income	6	6	7	7	7	9	6	4	4	6	4	0
Interest expense	15	16	16	16	16	16	15	12	11	20	8	7
Other non-operating income	−9	−9	35	3	−25	−35	349	9	9	−5	17	24
Income before tax	−2	−94	−34	22	44	56	−316	33	34	28	27	19
Income tax expense	5	−111	8	5	12	1	12	6	7	−3	4	−90
Net income from continuing operations	−7	16	−42	16	33	56	−327	27	27	31	22	109
Net income	−7	16	−42	16	33	56	−327	27	27	31	22	109
EPS, basic	−$0.14	$0.30	−$0.78	$0.30	$0.61	$1.03	−$6.01	$0.50	$0.49	$0.57	$0.41	$1.98
EPS, diluted	−$0.14	$0.30	−$0.78	$0.30	$0.60	$1.02	−$6.01	$0.50	$0.49	$0.57	$0.40	$1.93
Weighted average shares, basic	54	54	54	54	54	54	54	55	55	55	55	55
Weighted average shares, diluted	54	54	54	55	55	55	54	55	55	55	56	56
EBITDA	28	−63	−5	49	73	85	−286	61	57	47	51	26
Depreciation & amortization	15	16	13	12	13	13	15	15	12	0	16	0
EBIT	13	−79	−18	37	60	72	−300	46	45	47	35	26